313 related articles for article (PubMed ID: 20925202)
1. Circulating angiogenic factors in pregnancies complicated by pre-eclampsia.
Varughese B; Bhatla N; Kumar R; Dwivedi SN; Dhingra R
Natl Med J India; 2010; 23(2):77-81. PubMed ID: 20925202
[TBL] [Abstract][Full Text] [Related]
2. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.
Molvarec A; Szarka A; Walentin S; Szucs E; Nagy B; Rigó J
Hypertens Res; 2010 Sep; 33(9):892-8. PubMed ID: 20535121
[TBL] [Abstract][Full Text] [Related]
3. Circulating angiogenic factors and the risk of preeclampsia.
Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
[TBL] [Abstract][Full Text] [Related]
4. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
Cheng M; He P; Fu J
J Hum Hypertens; 2016 Dec; 30(12):788-793. PubMed ID: 27169826
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of endothelial dysfunction in preeclampsia and neonatal morbidity: a case-control study.
Masoura S; Kalogiannidis I; Makedou K; Theodoridis T; Koiou K; Gerou S; Athanasiadis A; Agorastos T
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():119-23. PubMed ID: 24485669
[TBL] [Abstract][Full Text] [Related]
6. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia.
Staff AC; Braekke K; Harsem NK; Lyberg T; Holthe MR
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):33-9. PubMed ID: 15935542
[TBL] [Abstract][Full Text] [Related]
7. Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pre-eclampsia.
Suwaki N; Masuyama H; Nakatsukasa H; Masumoto A; Sumida Y; Takamoto N; Hiramatrsu Y
Am J Obstet Gynecol; 2006 Dec; 195(6):1687-92. PubMed ID: 16769024
[TBL] [Abstract][Full Text] [Related]
8. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
[TBL] [Abstract][Full Text] [Related]
9. Assessment of angiogenesis modulators in pregnant women with pre-eclampsia: a case-control study.
Mundim GJ; Paschoini MC; Araujo Júnior E; Da Silva Costa F; Rodrigues Júnior V
Arch Gynecol Obstet; 2016 Feb; 293(2):369-75. PubMed ID: 26205065
[TBL] [Abstract][Full Text] [Related]
10. Maternal plasma VEGF, sVEGF-R1, and PlGF concentrations in preeclamptic and normotensive pregnant Zimbabwean women.
Muy-Rivera M; Vadachkoria S; Woelk GB; Qiu C; Mahomed K; Williams MA
Physiol Res; 2005; 54(6):611-22. PubMed ID: 15717861
[TBL] [Abstract][Full Text] [Related]
11. [PlGF and sFlt-1--diagnostic significance in preeclampsia prediction in pregnant women with gestational and chronic hypertension].
Manolov V; Marinov B; Vasilev V
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():61-9. PubMed ID: 24294749
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of the anti-angiogenic thrombospondin 2 are elevated in pre-eclampsia.
Stenczer B; Molvarec A; Veresh Z; Gullai N; Nagy GR; Walentin S; Szijártó J; Rigó J
Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1291-5. PubMed ID: 21682699
[TBL] [Abstract][Full Text] [Related]
13. First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia.
Odibo AO; Rada CC; Cahill AG; Goetzinger KR; Tuuli MG; Odibo L; Macones GA; England SK
J Perinatol; 2013 Sep; 33(9):670-4. PubMed ID: 23558430
[TBL] [Abstract][Full Text] [Related]
14. Establishing reference values for both total soluble Fms-like tyrosine kinase 1 and free placental growth factor in pregnant women.
Hirashima C; Ohkuchi A; Arai F; Takahashi K; Suzuki H; Watanabe T; Kario K; Matsubara S; Suzuki M
Hypertens Res; 2005 Sep; 28(9):727-32. PubMed ID: 16419645
[TBL] [Abstract][Full Text] [Related]
15. [Maternal serum concentration of placental growth factor (PIGF) and endothelial growth factor (VEGF) in pregnancies complicated by preeclampsia].
Semczuk-Sikora A; Krzyzanowski A; Kwiatek M; Semczuk M
Ginekol Pol; 2007 Nov; 78(11):873-6. PubMed ID: 18306920
[TBL] [Abstract][Full Text] [Related]
16. The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia.
Govender L; Mackraj I; Gathiram P; Moodley J
Cardiovasc J Afr; 2012 Apr; 23(3):153-9. PubMed ID: 22555639
[TBL] [Abstract][Full Text] [Related]
17. Early postpartum changes in circulating pro- and anti-angiogenic factors in early-onset and late-onset pre-eclampsia.
Wikström AK; Larsson A; Eriksson UJ; Nash P; Olovsson M
Acta Obstet Gynecol Scand; 2008; 87(2):146-53. PubMed ID: 18231881
[TBL] [Abstract][Full Text] [Related]
18. Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia.
Ben Ali Gannoun M; Bourrelly S; Raguema N; Zitouni H; Nouvellon E; Maleh W; Brahim Chemili A; Elfeleh R; Almawi W; Mahjoub T; Gris JC
Cytokine; 2016 Mar; 79():1-6. PubMed ID: 26702929
[TBL] [Abstract][Full Text] [Related]
19. Soluble fms-like tyrosine kinase-1 in HIV infected pre-eclamptic South African Black women.
Govender N; Moodley J; Gathiram P; Naicker T
Placenta; 2014 Aug; 35(8):618-24. PubMed ID: 24880209
[TBL] [Abstract][Full Text] [Related]
20. The performance of pre-delivery serum concentrations of angiogenic factors in predicting postpartum antihypertensive drug therapy following abdominal delivery in severe preeclampsia and normotensive pregnancy.
Ngene NC; Moodley J; Naicker T
PLoS One; 2019; 14(4):e0215807. PubMed ID: 31022243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
